Erratum: On behalf of the REGULATE-PCI Investigators (Effect of the REG1 anticoagulation system versus bivalirudin on outcomes after percutaneous coronary intervention (REGULATE-PCI): A randomised clinical trial. (The Lancet (2016) 387 (34956))
Publication
, Journal Article
Lincoff, AM; Mehran, R; Povsic, TJ
Published in: The Lancet
March 19, 2016
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
The Lancet
DOI
EISSN
1474-547X
ISSN
0140-6736
Publication Date
March 19, 2016
Volume
387
Issue
10024
Start / End Page
1162
Related Subject Headings
- General & Internal Medicine
- 42 Health sciences
- 32 Biomedical and clinical sciences
- 11 Medical and Health Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Lincoff, A. M., Mehran, R., & Povsic, T. J. (2016). Erratum: On behalf of the REGULATE-PCI Investigators (Effect of the REG1 anticoagulation system versus bivalirudin on outcomes after percutaneous coronary intervention (REGULATE-PCI): A randomised clinical trial. (The Lancet (2016) 387 (34956)). The Lancet, 387(10024), 1162. https://doi.org/10.1016/S0140-6736(15)00399-2
Lincoff, A. M., R. Mehran, and T. J. Povsic. “Erratum: On behalf of the REGULATE-PCI Investigators (Effect of the REG1 anticoagulation system versus bivalirudin on outcomes after percutaneous coronary intervention (REGULATE-PCI): A randomised clinical trial. (The Lancet (2016) 387 (34956)).” The Lancet 387, no. 10024 (March 19, 2016): 1162. https://doi.org/10.1016/S0140-6736(15)00399-2.
Lincoff AM, Mehran R, Povsic TJ. Erratum: On behalf of the REGULATE-PCI Investigators (Effect of the REG1 anticoagulation system versus bivalirudin on outcomes after percutaneous coronary intervention (REGULATE-PCI): A randomised clinical trial. (The Lancet (2016) 387 (34956)). The Lancet. 2016 Mar 19;387(10024):1162.
Lincoff, A. M., et al. “Erratum: On behalf of the REGULATE-PCI Investigators (Effect of the REG1 anticoagulation system versus bivalirudin on outcomes after percutaneous coronary intervention (REGULATE-PCI): A randomised clinical trial. (The Lancet (2016) 387 (34956)).” The Lancet, vol. 387, no. 10024, Mar. 2016, p. 1162. Scopus, doi:10.1016/S0140-6736(15)00399-2.
Lincoff AM, Mehran R, Povsic TJ. Erratum: On behalf of the REGULATE-PCI Investigators (Effect of the REG1 anticoagulation system versus bivalirudin on outcomes after percutaneous coronary intervention (REGULATE-PCI): A randomised clinical trial. (The Lancet (2016) 387 (34956)). The Lancet. 2016 Mar 19;387(10024):1162.
Published In
The Lancet
DOI
EISSN
1474-547X
ISSN
0140-6736
Publication Date
March 19, 2016
Volume
387
Issue
10024
Start / End Page
1162
Related Subject Headings
- General & Internal Medicine
- 42 Health sciences
- 32 Biomedical and clinical sciences
- 11 Medical and Health Sciences